Literature DB >> 10477620

Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity.

C Jobin1, C A Bradham, M P Russo, B Juma, A S Narula, D A Brenner, R B Sartor.   

Abstract

NF-kappa B plays a critical role in the transcriptional regulation of proinflammatory gene expression in various cells. Cytokine-mediated activation of NF-kappa B requires activation of various kinases, which ultimately leads to the phosphorylation and degradation of I kappa B, the NF-kappa B cytoplasmic inhibitor. The food derivative curcumin has been shown to inhibit NF-kappa B activity in some cell types. In this report we investigate the mechanism of action of curcumin on cytokine-induced proinflammatory gene expression using intestinal epithelial cells (IEC). Curcumin inhibited IL-1 beta-mediated ICAM-1 and IL-8 gene expression in IEC-6, HT-29, and Caco-2 cells. Cytokine-induced NF-kappa B DNA binding activity, RelA nuclear translocation, I kappa B alpha degradation, I kappa B serine 32 phosphorylation, and I kappa B kinase (IKK) activity were blocked by curcumin treatment. Wound-induced p38 phosphorylation was not inhibited by curcumin treatment. In addition, mitogen-activated protein kinase/ERK kinase kinase-1-induced IL-8 gene expression and 12-O-tetraphorbol 12-myristate 13-acetate-responsive element-driven luciferase expression were inhibited by curcumin. However, I kappa B alpha degradation induced by ectopically expressed NF-kappa B-inducing kinase or IKK was not inhibited by curcumin treatment. Therefore, curcumin blocks a signal upstream of NF-kappa B-inducing kinase and IKK. We conclude that curcumin potently inhibits cytokine-mediated NF-kappa B activation by blocking a signal leading to IKK activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477620

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  185 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 2.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 3.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

4.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

5.  Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation.

Authors:  Christian Kliem; Anette Merling; Marco Giaisi; Rebecca Köhler; Peter H Krammer; Min Li-Weber
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

6.  Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells.

Authors:  J S Kim; A S Narula; C Jobin
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

7.  Dietary curcumin supplementation does not alter peripheral blood mononuclear cell responses to exertional heat stress.

Authors:  Peter A Falgiano; Trevor L Gillum; Zach J Schall; Harrison R Strag; Matthew R Kuennen
Journal:  Eur J Appl Physiol       Date:  2018-10-01       Impact factor: 3.078

8.  Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Authors:  Matthew Miller; Shenglin Chen; Jeffrey Woodliff; Sanjay Kansra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.

Authors:  Yan Jiao; John Wilkinson; Xiumin Di; Wei Wang; Heather Hatcher; Nancy D Kock; Ralph D'Agostino; Mary Ann Knovich; Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

10.  Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.

Authors:  C B Larmonier; J K Uno; Kang-Moon Lee; T Karrasch; D Laubitz; R Thurston; M T Midura-Kiela; F K Ghishan; R B Sartor; C Jobin; P R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-25       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.